What do other countries do in the drug approval process that could be implemented by the US to improve drug approval timelines?

A) Maintain the existing US drug approval process without changes.
B) Adopt a more rigorous and time-consuming evaluation process to ensure safety.
C) Incorporate streamlined regulatory practices from other countries to expedite the drug approval timeline.
D) Rely solely on internal research and disregard international collaboration in the drug approval process.